110 related articles for article (PubMed ID: 21074639)
1. Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands.
van de Schans SA; van Spronsen DJ; Hooijkaas H; Janssen-Heijnen ML; Coebergh JW
Autoimmun Rev; 2011 Feb; 10(4):228-34. PubMed ID: 21074639
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
4. Cancer among children of parents with autoimmune diseases.
Mellemkjaer L; Alexander F; Olsen JH
Br J Cancer; 2000 Apr; 82(7):1353-7. PubMed ID: 10755414
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer and inflammation.
Guarino V; Castellone MD; Avilla E; Melillo RM
Mol Cell Endocrinol; 2010 May; 321(1):94-102. PubMed ID: 19835928
[TBL] [Abstract][Full Text] [Related]
6. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
7. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
[TBL] [Abstract][Full Text] [Related]
8. [Trends in the incidence and prevalence of cancer and in the survival of patients in southeastern Netherlands, 1970-1999].
Janssen-Heijnen ML; Louwman WJ; van de Poll-Franse LV; Voogd AC; Houterman S; Coebergh JW
Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1118-26. PubMed ID: 12822522
[TBL] [Abstract][Full Text] [Related]
9. The immunologic capability of patients with lymphoma.
Miller DG
Cancer Res; 1968 Jul; 28(7):1441-8. PubMed ID: 5665992
[No Abstract] [Full Text] [Related]
10. [Autoimmune diseases and malignant lymphoma].
Müller-Hermelink HK; Greiner A
Verh Dtsch Ges Pathol; 1992; 76():96-109. PubMed ID: 1283281
[TBL] [Abstract][Full Text] [Related]
11. Where the immune response meets the vessel wall.
Bisoendial RJ; Stroes ES; Tak PP
Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659
[TBL] [Abstract][Full Text] [Related]
12. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of receiving a total hip replacement in cancer patients.
Dybvik E; Furnes O; Fosså SD; Trovik C; Lie SA
Cancer Epidemiol; 2009 Oct; 33(3-4):235-41. PubMed ID: 19744907
[TBL] [Abstract][Full Text] [Related]
15. Hyperinfection with strongyloides in lymphomas.
MacGregor GA
Br Med J; 1973 Mar; 1(5856):802. PubMed ID: 4694443
[No Abstract] [Full Text] [Related]
16. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
17. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience.
Alonso-Llamazares J; Gibson LE; Rogers RS
Int J Dermatol; 2007 Sep; 46(9):910-9. PubMed ID: 17822491
[TBL] [Abstract][Full Text] [Related]
18. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).
Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104
[TBL] [Abstract][Full Text] [Related]
19. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
Pasquet F; Pavic M; Ninet J; Hot A
Rev Med Interne; 2014 May; 35(5):310-6. PubMed ID: 24268698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
